Tag: CBT > FDA Approved Cannabis Product

Cannabis Industry Research

The Man Behind DEA’s Federal Marijuana Scam

DEA Senior Policy Adviser Matthew Strait defied presidential mandates for medical research, MMJ International Holdings claims.

January 28, 2025

Industry Headlines

Attorney General, DEA Director, Judge Under Federal Court Summons Over DEA Marijuana Policy

Despite the DEA’s policy, MMJ International is moving forward with the FDA on cannabis drug development for Huntington’s disease.

January 6, 2025

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

Cannabis Advertising

The Complex Impact of Rescheduling Cannabis on Advertising

The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.

September 17, 2024

Cannabis Packaging Regulations

FTC, FDA Send Cease-and-Desist Letters to 5 Companies Selling Delta-8 THC Products Appealing to Children

The federal agencies called out the firms for putting kids’ health at risk for the sake of profit.

July 16, 2024

Legislation and Regulation

FDA Chooses LightLab 3 Cannabis Analyzer to Enhance Consumer Safety, Regulate the Industry

The administration’s decision stems from concerns associated with food-related products containing CBD and Delta-8 THC.

August 25, 2023

CBD Industry

Hemp Numbers Plummet Across the Board in 2022 USDA Acreage and Production Survey

The value of industrial hemp totaled $238 million in 2022, down 71% from $824 million in 2021.

April 28, 2023

CBD Industry

US Lawmakers Reintroduce Bipartisan Bills to Regulate CBD

The reintroduction of the measures comes after the FDA called on Congress to regulate CBD in dietary supplements, conventional foods and animal products.

March 17, 2023

Top Stories

Question: Will the FDA Take Steps to Regulate CBD This Year? Answer: Well… Maybe.

Industry stakeholders weigh in after FDA officials told reporters last month that the agency plans to review product regulations in the coming months.

January 13, 2023

Cannabis Rescheduling

Helpful, or Yet Another Hurdle?

Many industry experts agree President Joe Biden’s three-step cannabis reform plan was historic and removing the plant from the list of Controlled Substances would be ideal. But a rescheduling could make things more complex—or even a 'disaster'—for state-legal markets.

December 23, 2022

Legislation and Regulation

UPDATED: President Biden Signs Bipartisan Cannabis Research Bill

The legislation cleared its final congressional hurdle with a voice vote last month in the Senate, paving way for researchers to fully study the impacts of cannabis use.

December 2, 2022

Legislation and Regulation

National Industrial Hemp Council Urges FDA to Approve Hemp Seed for Animal Feed

The NIHC sent a letter to the FDA, calling for the federal agency to approve hemp seed as a viable feed alternative for livestock producers.

November 7, 2022